FDA approves Bydureon as adjunct treatment of type 2 diabetes. In a letter posted to the Food and Drug Administration website, the FDA said that Bydureon was approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus in multiple clinical settings. The drug approval is effective on the date of the letter, for use as recommended in the agreed-upon labeling text, the letter stated. See this week's Item #7.

Free Handouts for medical professionals to give to their patients with diabetes. Over 50 Diabetes handouts in English, Spanish. Learning About Diabetes, Inc., is a non-profit charity providing consumers and health care professionals with simply written information on diabetes care. An area of special interest is using art and design in novel ways to help readers better understand this often complex health care problem. The goal or mission of Learning About Diabetes, Inc., is to provide free, easy-to-understand diabetes self-care information to diabetes educators, people with diabetes, and the general public. Learning About Diabetes

One holy grail of medical technology research has been the possibility of measuring patients' blood glucose levels indirectly, avoiding the universally hated needle pricks. Not only will this make millions of diabetes patients jump with joy, it will certainly increase their testing compliance, leading to better management of the disease. Just follow this link for information on the Glucose BioChip.

Test Your Knowledge #610

Results from a pooled analysis evaluating the benefits of initiating insulin to metformin at an earlier versus later treatment stage, with or without sulfonylurea showed.... See this week's Test Your Knowledge Question